TrialDrug design, development and therapy2016

Insulin sensitizer in prediabetes: a clinical study with DLBS3233, a combined bioactive fraction of Cinnamomum burmanii and Lagerstroemia speciosa.

Asman Manaf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.